Abstract
ERG11 sequencing of 28 Candida auris clade III isolates revealed the presence of concomitant V125A and F126L substitutions. Heterologous expression of Erg11-V125A/F126L in Saccharomyces cerevisiae led to reduced fluconazole and voriconazole susceptibilities. Generation of single substitution gene variants through site-directed mutagenesis uncovered that F126L primarily contributes to the elevated triazole MICs. A similar yet diminished pattern of reduced susceptibility was observed with the long-tailed triazoles posaconazole and itraconazole for the V125A/F126L, F126L, Y132F, and K143R alleles.
| Original language | English |
|---|---|
| Article number | e01624-21 |
| Journal | Antimicrobial Agents and Chemotherapy |
| Volume | 66 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- African clade
- Azole resistance
- Candida auris
- Clade III
- ERG11
- Fluconazole resistance
- Heterologous expression
- Mutagenesis
- Short- and long-tailed triazoles
Fingerprint
Dive into the research topics of 'Impact of Erg11 Amino Acid Substitutions Identified in Candida auris Clade III Isolates on Triazole Drug Susceptibility'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver